Bulletin
Investor Alert

London Markets Open in:

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 18, 2022, 4:47 p.m.

/zigman2/quotes/206690250/composite

$

88.42

Change

0.00 0.00%

Volume

Volume 84,542

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Previous close

$ 92.90

$ 88.42

Change

-4.48 -4.82%

Day low

Day high

$87.74

$92.13

Open

52 week low

52 week high

$82.51

$120.54

Open

Miles W. McHugh

Miles W. McHugh occupies the position of Chief Accounting Officer & Senior Vice President for Horizon Therapeutics Plc.

In his past career Mr. McHugh held the position of Chief Financial Officer & Executive Vice President of R.R. Donnelley & Sons Co., Chief Financial Officer & Secretary for Transcontinental Holding Corp., Chief Financial Officer & Vice President for RR Donnelley Logistics Services Worldwide, Inc., Controller for DPL, Inc. and Chief Accounting Officer & Senior Vice President for R1 RCM, Inc.

Miles W. McHugh received an MBA from The University of Chicago Booth School of Business and an undergraduate degree from the University of Illinois.

Transactions

Date Shares Transaction Value
01/05/2022 8,175   Derivative/Non-derivative trans. at $101.84 per share. 832,542
01/05/2022 18,289   Derivative/Non-derivative trans. at $0 per share. 0
12/01/2021 79,484   Disposition at $106.62 per share. 8,474,585
12/01/2021 79,484   Derivative/Non-derivative trans. at $22.14 per share. 1,759,775
06/10/2021 1,477   Derivative/Non-derivative trans. at $93.95 per share. 138,765
06/10/2021 3,334   Derivative/Non-derivative trans. at $0 per share. 0
01/21/2021 1,591   Derivative/Non-derivative trans. at $77.43 per share. 123,192
01/21/2021 3,590   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2021 9,621   Derivative/Non-derivative trans. at $73.28 per share. 705,027
01/05/2021 21,496   Derivative/Non-derivative trans. at $0 per share. 0
12/14/2020 1,856   Disposition at $80 per share. 148,480
11/12/2020 12,124   Disposition at $75.48 per share. 915,120
06/10/2020 1,477   Derivative/Non-derivative trans. at $48.6 per share. 71,783
06/10/2020 3,333   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2020 49,114   Disposition at $44.22 per share. 2,171,822
05/08/2020 45,366   Disposition at $43.51 per share. 1,973,875
05/08/2020 3,799   Gift at $0 per share. 0
05/06/2020 3,545   Disposition at $41.19 per share. 146,019
05/05/2020 5,007   Disposition at $37 per share. 185,259
02/27/2020 1,000   Disposition at $34.34 per share. 34,340
01/21/2020 1,591   Derivative/Non-derivative trans. at $38.25 per share. 60,856
01/21/2020 3,590   Award at $0 per share. 0
01/05/2020 7,139   Derivative/Non-derivative trans. at $36.1 per share. 257,718
01/05/2020 15,691   Derivative/Non-derivative trans. at $0 per share. 0
11/14/2019 4,516   Derivative/Non-derivative trans. at $22.14 per share. 99,984
08/01/2019 11,076   Derivative/Non-derivative trans. at $24.97 per share. 276,568
08/01/2019 25,000   Derivative/Non-derivative trans. at $0 per share. 0
06/10/2019 1,477   Derivative/Non-derivative trans. at $23.36 per share. 34,503
06/10/2019 3,333   Derivative/Non-derivative trans. at $0 per share. 0
03/23/2019 4,209   Derivative/Non-derivative trans. at $26.84 per share. 112,970
03/23/2019 9,500   Derivative/Non-derivative trans. at $0 per share. 0
01/22/2019 16,406   Derivative/Non-derivative trans. at $12.19 per share. 199,989
01/05/2019 3,312   Derivative/Non-derivative trans. at $20.39 per share. 67,532
01/05/2019 6,700   Derivative/Non-derivative trans. at $0 per share. 0
12/26/2018 16,406   Derivative/Non-derivative trans. at $12.19 per share. 199,989
12/01/2018 3,744   Derivative/Non-derivative trans. at $19.98 per share. 74,806
12/01/2018 8,450   Derivative/Non-derivative trans. at $0 per share. 0
08/01/2018 11,075   Derivative/Non-derivative trans. at $17.72 per share. 196,249
08/01/2018 25,000   Derivative/Non-derivative trans. at $0 per share. 0
03/23/2018 4,209   Derivative/Non-derivative trans. at $13.86 per share. 58,337
03/23/2018 9,500   Derivative/Non-derivative trans. at $0 per share. 0
12/01/2017 2,730   Derivative/Non-derivative trans. at $14.33 per share. 39,121
12/01/2017 8,450   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.